Matthew M. Halpert

641 total citations
19 papers, 430 citations indexed

About

Matthew M. Halpert is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Matthew M. Halpert has authored 19 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Matthew M. Halpert's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Matthew M. Halpert is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Matthew M. Halpert collaborates with scholars based in United States, Mexico and South Korea. Matthew M. Halpert's co-authors include William K. Decker, Vanaja Konduri, Jonathan Vazquez‐Perez, Jonathan M. Levitt, Dan Liang, Kenneth Dunner, Pedram Salimpour, Christopher D. Verrico, Scott A. Weldon and Silke Paust and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Matthew M. Halpert

17 papers receiving 426 citations

Peers

Matthew M. Halpert
Vanaja Konduri United States
Joseph Taylor United Kingdom
Robin McGoey United States
Yi Gao China
Federico Penas Argentina
Hasna Baidouri United States
Sagie Wagage United States
T Oku Japan
Vanaja Konduri United States
Matthew M. Halpert
Citations per year, relative to Matthew M. Halpert Matthew M. Halpert (= 1×) peers Vanaja Konduri

Countries citing papers authored by Matthew M. Halpert

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Halpert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Halpert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Halpert more than expected).

Fields of papers citing papers by Matthew M. Halpert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Halpert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Halpert. The network helps show where Matthew M. Halpert may publish in the future.

Co-authorship network of co-authors of Matthew M. Halpert

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Halpert. A scholar is included among the top collaborators of Matthew M. Halpert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Halpert. Matthew M. Halpert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Halpert, Matthew M., Spencer R. Rosario, Henry Withers, et al.. (2024). Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy. The FASEB Journal. 38(10). e23644–e23644.
2.
Konduri, Vanaja, Jonathan Vazquez‐Perez, Scott A. Weldon, et al.. (2021). CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential. Frontiers in Immunology. 11. 613204–613204. 67 indexed citations
3.
Konduri, Vanaja, Sujith K. Joseph, Tiara T. Byrd, et al.. (2021). A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma. Science Translational Medicine. 13(592). 19 indexed citations
4.
Verrico, Christopher D., Vanaja Konduri, Jonathan Vazquez‐Perez, et al.. (2020). A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain. 161(9). 2191–2202. 127 indexed citations
5.
Halpert, Matthew M., Vanaja Konduri, Dan Liang, et al.. (2020). MHC class I and II peptide homology regulates the cellular immune response. The FASEB Journal. 34(6). 8082–8101. 10 indexed citations
6.
Halpert, Matthew M., Vanaja Konduri, Jonathan Vazquez‐Perez, et al.. (2020). A Randomized, Double-Blind, Placebo-Controlled Study of Daily Cannabidiol for the Treatment of Canine Osteoarthritis. The Journal of Immunology. 204(1_Supplement). 67.11–67.11. 2 indexed citations
7.
Konduri, Vanaja, Matthew M. Halpert, John R. Rodgers, et al.. (2019). Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Cancer Gene Therapy. 26(9-10). 282–291. 11 indexed citations
8.
Liang, Dan, Lin Tian, Ran You, et al.. (2018). AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity. Frontiers in Immunology. 8. 1801–1801. 25 indexed citations
9.
Halpert, Matthew M., Vanaja Konduri, Yunyu Chen, et al.. (2018). Regulation and In Vivo Function of Dendritic Cell CTLA-4. The Journal of Immunology. 200(Supplement_1). 109.11–109.11. 2 indexed citations
10.
Konduri, Vanaja, Matthew M. Halpert, Dan Liang, et al.. (2017). Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy. Infection and Immunity. 85(9). 13 indexed citations
11.
Halpert, Matthew M., Vanaja Konduri, Yunyu Chen, et al.. (2017). Abstract LB-201: Durable remission of lethal canine hemangiosarcoma. Cancer Research. 77(13_Supplement). LB–201.
12.
Halpert, Matthew M., Vanaja Konduri, Dan Liang, et al.. (2016). Dendritic Cell-Secreted Cytotoxic T-Lymphocyte-Associated Protein-4 Regulates the T-cell Response by Downmodulating Bystander Surface B7. Stem Cells and Development. 25(10). 774–787. 43 indexed citations
13.
Konduri, Vanaja, Dali Li, Matthew M. Halpert, et al.. (2016). Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53−/−pancreatic ductal adenocarcinoma. OncoImmunology. 5(9). e1213933–e1213933. 21 indexed citations
14.
Liang, Dan, Matthew M. Halpert, Vanaja Konduri, & William K. Decker. (2015). Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity. International Reviews of Immunology. 34(5). 367–381. 16 indexed citations
15.
Konduri, Vanaja, William K. Decker, Matthew M. Halpert, Brian E. Gilbert, & Amar Safdar. (2013). Modeling Dendritic Cell Vaccination for Influenza Prophylaxis: Potential Applications for Niche Populations. The Journal of Infectious Diseases. 207(11). 1764–1772. 8 indexed citations
16.
Couch, Robert B., William K. Decker, Budi Utama, et al.. (2012). Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans. PLoS ONE. 7(12). e50830–e50830. 41 indexed citations
17.
Decker, William K., Nina Shah, Dongxia Xing, et al.. (2012). Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC. PLoS ONE. 7(12). e51390–e51390. 5 indexed citations
18.
Halpert, Matthew M., David M. Spencer, Ratan D. Bhardwaj, Michael E. Berens, & William K. Decker. (2012). Abstract LB-132: The potential role of the multienzyme aminoacyl-tRNA synthetase complex in Th-1 immunity: implications for cancer immunotherapy. Cancer Research. 72(8_Supplement). LB–132. 1 indexed citations
19.
Halpert, Matthew M., Kimberly A. Thomas, R. Glenn King, & Louis B. Justement. (2011). TLT2 Potentiates Neutrophil Antibacterial Activity and Chemotaxis in Response to G Protein-Coupled Receptor-Mediated Signaling. The Journal of Immunology. 187(5). 2346–2355. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026